ASX Announcements

Filter by Year: 2019 2018 2017 2016
Change in Noxopharm Limited Board Structure
Idronoxil Confirmed as New Immuno-Oncology Drug
Veyonda Chemotherapy Enhancement Program to be Expanded
Securities to be released from Voluntary Escrow
Updated Top 20 shareholder List
Appendix 3B
Section 708 Certificate
Becoming a substantial holder
KZA: Kazia sells stake in Noxopharm
NOX provides update to Nyrada Note Holders

1 2 Next